KrasG12D.Map3k7−/−.GFP+ murine lung cancer cell line

A novel syngeneic KrasG12D.Map3k7-/-.GFP+ murine lung cancer cell line (E889) with orthotopic growth potential, that can serve as a useful preclinical model for evaluating tumour-host interactions, the impact of specific oncogenic alterations on the tumor microenvironment, and immunotherapeutic approaches.. This cell line was derived from the primary lung tumour of a KrasLSL-G12D/+.Map3k7fl/fl. ROSAmTmG male C57BL/6 […]

Contributors

Inventor Institute
Stephen Malkoski The University of Colorado Anschutz Medical Campus
Cat. #: 162386
Cancer types: Lung cancer
Research Fields: Cancer biology; Immunotherapy
Organism: Mouse
Tissue: Lung
Gender: Male
Primary citation: Nolan et al. 2020. Cancer Cell Int. 28: 20:417. PMID: 32874131
Alternate name: KrasG12D.Map3k7−/−.GFP+ cell line; E889 cell line
Product description: A novel syngeneic KrasG12D.Map3k7-/-.GFP+ murine lung cancer cell line (E889) with orthotopic growth potential, that can serve as a useful preclinical model for evaluating tumour-host interactions, the impact of specific oncogenic alterations on the tumor microenvironment, and immunotherapeutic approaches. This cell line was derived from the primary lung tumour of a KrasLSL-G12D/+.Map3k7fl/fl. ROSAmTmG male C57BL/6 mouse and is capable of forming orthotopic tumours in immunocompetent C57BL/6 mice. E889 cells demonstrate genetic recombination at the Kras and Map3k7 loci as shown by PCR, and express KRASG12D but not MAP3K7, as shown by western analysis. As this cell line was derived from an animal harboring the ROSAmTmG tracking allele, it also expresses GFP.
Gender: Male
Production details: An 8 week old KrasLSL-G12D/+.Map3k7fl/fl. ROSAmTmG male mouse was injected with 2 µl of 10^9 PFU/ml Ad5-CMV-Cre into the left lung. When this animal was euthanized 26 week later, an 8 mm primary tumour was passaged into a male recipient. After two passages through the flanks of recipient animals, the KrasG12D.Map3k7-/-.GFP+ cell line (E889) was established that was capable of forming orthotopic tumors in immunocompetent C57BL/6 animals.
disease: Cancer
Format: Frozen
Storage conditions: Liquid Nitrogen
Shipping conditions: Dry ice
Growth medium: Dulbecco's Modified Eagle Medium (DMEM) containing 4.5 g/l d-glucose, l-glutamine, and sodium pyruvate, supplemented with 10% (v/v) fetal bovine serum and 100 μg/ml of primocin (optional)
Subculture routine: Split 90% confluent cultures 1:5 to 1:15 as required. Cells are cultured at 37°C, in a humidified incubator with 5% CO2.
Temperature: 37°C
Atmosphere: 5% CO2
Biosafety level: 1
References:

Nolan et al. 2020. Cancer Cell Int. 28: 20:417. PMID: 32874131

Related Tools for Cell lines

Cat. # Tool Name
151445 1-7HB2 Cell Line Key Info View Tool
151450 JIM3 Cell Line Key Info View Tool
151503 1-7 CE1 Cell Line Key Info View Tool
151626 A375P beta6-puro Cell Line Key Info View Tool
151655 FLYA-13 Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.